Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
9,39 USD | -7,49% | -7,49% | +11,12% |
Attività
Numero di dipendenti: 112
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Drug Delivery Technology and Immune-oncology Therapeutics
100,0
%
| - | - | 19 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 19 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mary Szela
CEO | Chief Executive Officer | 60 | 01/01/18 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10/08/23 |
Steven Katz
CTO | Chief Tech/Sci/R&D Officer | 49 | 10/08/23 |
Bryan Cox
CTO | Chief Tech/Sci/R&D Officer | 62 | 10/08/23 |
Jennifer Stevens
LAW | General Counsel | 63 | 10/08/23 |
Richard Marshak
PRN | Corporate Officer/Principal | 65 | 10/08/23 |
Jodi Devlin
PRN | Corporate Officer/Principal | - | 05/09/23 |
James Alecxih
PRN | Corporate Officer/Principal | 59 | 10/08/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Kerry Hicks
BRD | Director/Board Member | 64 | 10/08/23 |
Mats Wahlström
CHM | Chairman | 70 | 10/08/23 |
George Martin
BRD | Director/Board Member | 65 | 10/08/23 |
David Matlin
BRD | Director/Board Member | 62 | 10/08/23 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10/08/23 |
Mary Szela
CEO | Chief Executive Officer | 60 | 01/01/18 |
Director/Board Member | 82 | 10/08/23 | |
Arjun Desai
BRD | Director/Board Member | 42 | 10/08/23 |
Anil Singhal
BRD | Director/Board Member | 72 | 10/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 27 159 327 | 12 603 654 ( 46,41 %) | 0 | 46,41 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,12% | 272 Mln | |
+8,63% | 115 Mrd | |
+13,17% | 107 Mrd | |
-12,76% | 22,31 Mrd | |
-3,99% | 21,6 Mrd | |
-7,19% | 18,23 Mrd | |
-39,93% | 17,62 Mrd | |
+6,67% | 14,26 Mrd | |
+33,90% | 12,37 Mrd | |
-28,60% | 8,28 Mrd |
- Borsa valori
- Azioni
- Azione TLSI
- Società TriSalus Life Sciences, Inc.